LoginRegister
    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCOManufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO
    Netmeds acquires health tech startup KiViHealth with Rs 70 crore investment commitmentNetmeds acquires health tech startup KiViHealth with Rs 70 crore investment commitment
    Lupin, YL Biologics gets PMDA approval for Etanercept biosimilar in JapanLupin, YL Biologics gets PMDA approval for Etanercept biosimilar in Japan
    Lupin gets USFDA nod to Sildenafil tablets to treat erectile dysfunctionLupin gets USFDA nod to Sildenafil tablets to treat erectile dysfunction
    Sun Pharma gets one observation from USFDA for Baska plantSun Pharma gets one observation from USFDA for Baska plant
    Government notifies Drugs and Clinical Trial Rules 2019Government notifies Drugs and Clinical Trial Rules 2019
    Fujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB togetherFujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB together
    OxyContin maker Purdue Pharma agrees to settle Oklahoma opioid case: SourceOxyContin maker Purdue Pharma agrees to settle Oklahoma opioid case: Source
    Biogen announces $5 billion buyback days after shelving Alzheimers trialsBiogen announces $5 billion buyback days after shelving Alzheimers trials
    Radiologists find new use of Amazon Alexa, Google Home during Medical ProceduresRadiologists find new use of Amazon Alexa, Google Home during Medical Procedures
    Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud caseCourt allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case
    Thermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar dealThermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar deal
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X